AVATAR MEDICAL Receives FDA Clearance For its Virtual Reality Surgical Planning Solution

June 6, 2023 Press Release

MOUNTAIN VIEW, Calif. & PARIS, June 06, 2023–(BUSINESS WIRE)–Medtech startup AVATAR MEDICAL announced today that its virtual reality (VR) surgical planning solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

AVATAR MEDICAL helps surgeons better prepare their procedures through the use of virtual reality (VR) representations of their patients. These patient avatars are generated instantly from CT scan or MRI images with an underlying proprietary technology based on four years of research in human-data interaction and machine learning conducted at the Institut Pasteur and Institut Curie. They serve as valuable tools for pre-operative planning and can also be displayed during surgical procedures.

More than 100 surgeons from 20 different hospitals and universities, including UMass, CUNY and Columbia University, have benefited from the solution. To date, it has been used for case studies, student education and patient engagement, leading to 6 medical publications.

“AVATAR MEDICAL is a unique hardware agnostic XR software platform. With the ability to plan based on preoperative imaging and then evaluate as well as confirm based on intraoperative imaging, I now have an additional level of capability and confidence in my advanced percutaneous and endovascular interventions.” Says Venkatesh Krishnasamy MD, Interventional Radiology, Associate Professor of Radiology, Columbia University

“After receiving tremendous positive feedback from surgeons over the past 3 years, the FDA’s clearance is a major milestone in getting our VR solution in their hands to care for their patients. We expect European medical device certification for next year”, says Xavier Wartelle, CEO of AVATAR MEDICAL.

About AVATAR MEDICAL
AVATAR MEDICAL is an innovative spin-off from the Institut Pasteur and Institut Curie. AVATAR MEDICAL was incorporated in Paris, France in July 2020 by an experienced team of French and American co-founders. It has an American subsidiary in Mountain View, California. Since its inception, the company has been recognized by prestigious competitions and programs including: Medtech Innovator, EIC Accelerator, Bpifrance i-Lab and i-Nov, the MedFIT award for the most innovative European startup, the Laval Virtual 2022 Grand Prix and the NVIDIA Inception program. https://avatarmedical.ai/

Contact:

Marie Buhot-Launay
VP, Sales and Marketing
marie@avatarmedical.ai
1 (603) 997 2349

Linkedin
Twitter
Vimeo
Medical Publications

About Peter Coffaro 506 Articles

Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.